Related Experiment Video
Updated: Dec 28, 2025
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Treatment of Peripheral Pulmonary Artery Stenosis
Chan W Kim1, Wilbert S Aronow, Tanya Dutta
1From the Department of Medicine, Cardiology Division, New York Medical College, Westchester Medical Center, Valhalla, NY.
Insights
Peripheral pulmonary artery stenosis (PAS) narrows lung arteries, affecting infants and children. Treatment options like balloon angioplasty and stent placement aim to improve blood flow and prevent heart complications.
Area of Science:
- Cardiology
- Pediatric Pulmonology
- Vascular Medicine
Background:
- Peripheral pulmonary artery stenosis (PAS) involves narrowing of the pulmonary arteries, impacting blood flow from the heart to the lungs.
- This condition can be congenital or acquired, with severity influenced by the cause, location, and extent of the narrowing.
- PAS commonly affects infants and children, presenting with symptoms like dyspnea, fatigue, and rapid heart rate, potentially leading to pulmonary hypertension and cardiac dysfunction.
Purpose of the Study:
- To review the current understanding of peripheral pulmonary artery stenosis (PAS).
- To outline the various treatment modalities available for PAS.
- To discuss the efficacy and limitations of different interventional procedures for PAS.
Main Methods:
- Literature review of peripheral pulmonary artery stenosis (PAS).
- Analysis of current treatment strategies including balloon angioplasty and stent placement.
- Evaluation of procedural outcomes and indications for each treatment.
Main Results:
- Simple balloon angioplasty is effective for proximal PAS.
- Cutting balloon angioplasty is suitable for resistant or distal PAS.
- Stent placement offers high efficacy but may require repeat interventions, reserved for refractory cases.
Conclusions:
- Peripheral pulmonary artery stenosis (PAS) requires tailored treatment based on stenosis characteristics.
- Interventional procedures like angioplasty and stenting are crucial for managing PAS.
- Further research may optimize long-term outcomes for pediatric patients with PAS.
Abstract:
Peripheral pulmonary artery stenosis (PAS) is an abnormal narrowing of the pulmonary vasculature and can form anywhere within the pulmonary artery tree. PAS is a congenital or an acquired disease, and its severity depends on the etiology, location, and number of stenoses. Most often seen in infants and young children, some symptoms include shortness of breath, fatigue, and tachycardia. Symptoms can progressively worsen over time as right ventricular pressure increases, leading to further complications including pulmonary artery hypertension and systolic and diastolic dysfunctions. The current treatment options for PAS include simple balloon angioplasty, cutting balloon angioplasty, and stent placement. Simple balloon angioplasty is the most basic therapeutic option for proximally located PAS. Cutting balloon angioplasty is utilized for more dilation-resistant PAS vessels and for more distally located PAS. Stent placement is the most effective option seen to treat the majority of PAS; however, it requires multiple re-interventions for serial dilations and is generally reserved for PAS vessels that are resistant to angioplasty.
More Related Videos
11:20A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
01:26Mitral Stenosis III: Medical Management
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...